三种抗氧化物质与牛血清白蛋白的相互作用

运用荧光光谱(FS)、紫外光谱(UV)和超滤(UF)法, 研究了阿魏酸、毛蕊异黄酮及芒柄花素三种抗氧化小分子物质与牛血清白蛋白(BSA)的结合反应. 以Lineweaver-Burk双倒数方程和能量传递原理分别计算了三者与BSA反应的结合常数(K_LB)和结合距离(r)以及由热力学参数的计算判断了三种小分子物质与BSA结合的作用力类型; 以Scatchard方程计算了三种小分子与BSA的结合常数(K_a)和结合位点数(n); 并对阿魏酸与毛蕊异黄酮及芒柄花素的竞争结合反应进行了研究. 实验结果表明: 这三种物质能与BSA结合形成非共价复合物, 导致BSA内源性荧光的静态猝灭; 它们与BSA的结合能力随着极性基团的增多、分子体积的增大而减弱; 静电作用和疏水作用可能是它们与BSA结合的主要作用力; 阿魏酸与芒柄花素或毛蕊异黄酮会产生与BSA的竞争结合效应.     

水中硝基苯胺类化合物酶免疫化学分析技术研究

采用戊二醛法, 将4-硝基苯乙胺与牛血清蛋白(BSA)和卵清蛋白(OVA)共价偶联, 分别合成了免疫原4-硝基苯乙胺-BSA和包被原4-硝基苯乙胺-OVA, 经紫外分光光度计及飞行时间质谱扫描鉴定. 用合成的免疫抗原免疫新西兰大白兔, 并用合成的包被原进行间接竞争酶联免疫(ELISA)试验, 获得的抗血清效价达1∶32000. 方阵实验确定了包被抗原最佳浓度(0.5 mg/L)及抗血清最佳稀释度(1∶6000), 并建立了间接竞争ELISA方法. 工作曲线表明在1～1000 μg/L浓度范围内呈良好的线性关系, 该法IC₅₀值为(52.73±2.67) μg/L, 检测限为5.12 μg/L. 其它类似结构不干扰硝基苯胺的测定. 成功地建立了硝基苯胺类化合物的间接竞争酶免疫化学分析方法．     

Synthesis, Structure and Luminescence of a Novel 2D Cadmium Coordination Polymer with a Ligand Generated in situ

The hydrothermal reaction of 1,2-dicyanobenzene with NaN3 in the presence of Cd(NO3)2 affords a novel 2D cadmium tetrazolyl-benzoate,{Cd(tzbz)(H2O)}n (H2tzbz is 2-(5-tetrazolyl)-benzoate). The tzbz ligand is generated in situ through the 2+3 Sharpless cycloaddition reaction and hydrolyzation. Its crystal structure was determined by single-crystal X-ray diffraction method. The crystal crystallizes in the orthorhombic system,space group Pbca with a=9.6659(19),b=7.6366(15),c=25.964(5) ,V=1916.5(7) 3,Z=8,Mr=318.57,Dc= 2.208 g/cm3,F(000)=1232 and μ=2.276 mm-1. The Cd(Ⅱ) atom is coordinated by four tzbz ligands and one water molecule to form a severely distorted pentangle bipyramid. While each tzbz ligand connects to four Cd(Ⅱ) atoms in a μ4-η1,η2,η1,η1,η1 coordination mode to construct a 2D architecture of the title complex. Additionally,the title complex exhibits strong fluorescence at room temperature in the solid state.     

Synthesis and Crystal Structure of N-[4-(4-Methyl-phenylsulfamoyl)-phenyl]-4-methyl-1,2,3-thiadiazole-5-carboxamide

The crystal structure of the title compound (C17H16N4O3S2, Mr = 388.46) has been determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic, space group P21/c with a = 13.688(2), b = 16.704(3), c = 8.3308(12) , β = 99.474(6)o, V = 1878.8(5) 3, Mr = 388.46, Z = 4, Dc = 1.373 g/cm3, μ = 0.308 mm–1, F(000) = 808, R = 0.0389 and wR = 0.0917. X-ray analysis reveals that the crystal structure involves intermolecular N–H…O and N–H…N hydrogen bonds, which link the molecules into a layer parallel to the ac plane.     

Synthesis and Crystal Structure of 2-Amino-4- chloro-5-（4-methylbenzyl）-6-methylpyrimidine

The title compound 2-amino-4-chloro-5-(4-methylbenzyl)-6-methylpyrimidine (C26H28Cl2N6, Mr = 495.44) has been synthesized and its crystal structure was determined by single-crystal X-ray diffraction analysis. The crystal belongs to monoclinic, space group P21/c with a = 14.892(7), b = 6.129(3), c = 14.889(7) , β = 109.795(8)°, V = 1278.7(10) 3, Z = 2, F(000) = 520, Dc = 1.287 g/cm3, μ = 0.280 mm-1, the final R = 0.0577 and wR = 0.1589 for 1357 observed reflections with I > 2σ(I). A total of 6091 reflections were collected, of which 2257 were independent (Rint = 0.033). The X-ray analysis reveals that the chlorine atom and methyl of the title compound are disordered.     

PP/PC共混材料的研究概况

从加工方式对制备简单机械共混PP/PC共混物性能的影响,增容体系中增容剂的种类、增容效果和不同填充物对共混体系的增强效果三方面综述了近年来国内外对PP/PC共混材料的研究概况,指出了其研究方向和发展前景。     

Bcl-2蛋白结合底物时的诱导契合及高效抑制剂的柔性对接研究

Bcl-2蛋白是目前抗肿瘤药物研究很具前景的新靶点. Bcl-2蛋白与底物作用的活性腔生理情况下是蛋白与蛋白作用接触面大而平坦, 与底物结合时发生明显的诱导契合. 通过分析和比较Bcl-2蛋白和其高同源的Bcl-x_L蛋白的自由状态及与底物复合时的9个相关三维结构模型, 明确了蛋白及活性腔的骨架结构特征, 活性腔内的重要位点和关键残基, 及它们结合底物时发生的诱导契合. 基于以上认识, 采用柔性对接的方法得到了高亲和力的小分子抑制剂与Bcl-2蛋白的合理结合模式, 为以后设计合成新型高效Bcl-2蛋白抑制剂打下了坚实基础.     

人顶体酶三维结构的同源模建及其与KF950的分子对接研究

采用同源模建方法首次构建了人顶体酶的三维结构模型, 模型的可靠性经Ramachandran图和Profile_3D图验证. 采用InsightII/Binding site方法准确定位了人顶体酶的活性位点, 并研究了顶体酶重要功能残基在活性位点的立体分布. 在此基础上, 通过柔性分子对接方法首次阐明了顶体酶高效抑制剂KF950与靶酶活性位点的相互作用模式, 发现特异性的氢键相互作用是KF950产生高抑制活性的重要分子基础. 其研究结果将为合理设计新型顶体酶抑制剂, 寻找男性口服避孕药奠定坚实基础.     

N-[2-(4-甲基)嘧啶基]-N′-2-硝基苯磺酰脲的合成、晶体结构、生物活性及其与酵母AHAS的分子对接

合成了磺酰脲化合物N-[2-(4-甲基)嘧啶基]-N′-2-硝基苯磺酰脲,用元素分析、红外、核磁共振氢谱对产物进行了表征,培养并测定了其晶体结构.晶体属三斜晶系,P1空间群,晶胞参数a=0.54159(1)nm,b=1.1533(3)nm,c=1.1857(4)nm,α=83.907(6)°,β=81.048(5)°,γ=77.637(4)°,V=0.7126(4)nm3,Dc=1.572g/cm3,Z=2,F(000)=348,R=0.0659,wR=0.1217.在晶体结构中,杂环上的一个N原子与脲桥上邻近的N原子上的H构成分子内氢键.测定了对酵母AHAS的离体抑制活性,其抑制常数Ki为(2.48±0.35)×10-7mol/L.用分子对接方法,将目标化合物晶体结构对接到靶酶酵母AHAS的活性位点,发现对接完毕目标化合物的构象与复合物晶体中的磺酰脲分子构象接近,并得到了合理的生物活性预测值.该研究为进一步理解磺酰脲类的分子结构、药物活性并设计新的分子提供了帮助和指导.     

Synthesis and Crystal Structure of a New Glycinato Copper Compound

1 INTRODUCTION Amino acids (AA) are some of the most important biological ligands, and metal ions are known to par- ticipate in a variety of biological reactions, therefore, research on the coordination behavior of metal-ami- no acid complexes is one of the most essential ele- ments of chemical biology[1, 2]. For over three deca- des their structures have been of considerable inte- rest and importance in coordination chemistry[2, 3]. Studies of these relatively simple complexes may en- ha…